Vaginal suppositories (versions)

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to pharmaceutical industry, namely to homeopathic suppositories for treatment of fungal colpitis, vulvovaginitis, endometriosis, papillomas, cervical erosion, candidosis and vaginal dryness (versions). Homeopathic suppositories for treatment of fungal colpitis, vulvovaginitis, endometriosis, papillomas, cervical erosion, candidosis and vaginal dryness, contain Sea buckthorn oil, homeopathic oil extract, thuya oil, melaleuca oil, juniper oil, homeopathic essence of eucalyptus, homeopathic essence of elder flower, homeopathic essence of wormwood, thick extract of galium, thick extract of cimicifuga, base, taken in specified quantity. Homeopathic suppositories for treatment of fungal colpitis, vulvovaginitis, endometriosis, papillomas, cervical erosion, candidosis and vaginal dryness, containing Sea buckthorn oil, homeopathic oil extract, valerian oil, Melissa oil, Humulus lupulus oil, homeopathic essence of Viscum album, homeopathic essence of jaborandi, thick extract of galium, thick extract of cimicifuga, base, taken in specifies quantity. Homeopathic suppositories for treatment of fungal colpitis, vulvovaginitis, endometriosis, papillomas, cervical erosion, candidosis and vaginal dryness, containing homeopathic oil extract, beggar-ticks oil, homeopathic essence of lycopodium, homeopathic essence of cantharis, thick extract of galium, thick extract of cimicifuga, base, taken in specified quantity.

EFFECT: suppositories are efficient for treatment of fungal colpitis, vulvovaginitis, endometriosis, papillomas, cervical erosion, candidosis and vaginal dryness.

3 cl, 5 ex

 

The invention relates to pharmaceutical industry and relates to the creation of new homeopathic suppository, which may find use for the treatment of obesity, vulvovaginitis, endometriosis, papillomas, fibroids, and zrozii cervical and vaginal dryness Known medicines for treatment of inflammatory diseases of female genital organs.

Known vaginal suppositories for the treatment of Trichomonas and nespetsificheskogo of obesity (Patent RU №2114610), which include chemical nitazol.

Closest to the proposed invention are homeopathic suppositories for the treatment of fungal obesity, vulvovaginitis, endometriosis, papillomas, fibroids (Patent No. 2308963 "VAGINAL HOMEOPATHIC SUPPOSITORIES IN ANTICAN (OPTIONS)")containing sea buckthorn oil and homeopathic essences, characterized in that it further contains homeopathic essences of eucalyptus, homeopathic essences elderflower, homeopathic essences of sage, oil of thuja, tea tree oil, juniper oil, homeopathic oil extract, cocoa butter, beeswax, propolis, lanolin. The technical object of the present invention is to expand the range of pharmacological effects of the proposed structures.

The problem is solved is and the account of the composition of candles, which in addition to homeopathic essences of eucalyptus, elderflower, sage, sea buckthorn oil, oil of juniper, tea tree oil, oil of juniper, homeopathic oil extract, cocoa butter, beeswax, propolis, lanolin, additionally contain dense extract of lady's bedstraw and dense extract component with the following ratios in g suppository mass 2,

Sea buckthorn 0,18

Homeopathic oil extract 0,18

Oil of thuja 0,09

Tea tree oil 0,09

Juniper 0,09

Homeopathic essence of eucalyptus 0,09

Homeopathic essence elderflower 0,09

Homeopathic essence of wormwood 0,09

Dense extract of lady's bedstraw 0,1

Dense extract component 0,1

The basis of the rest

The second option is a suppositories containing sea buckthorn oil, homeopathic oil extract, homeopathic essence of mistletoe, cocoa butter, beeswax, propolis, lanolin, additionally contains Valerian oil, Melissa oil, hop oil, homeopathic essence of jaborandi, mistletoe, dense extract of lady's bedstraw and dense extract component with the following ratios of components in g on 1 suppository mass 2,

Sea buckthorn 0,18

Homeopathic oil extract 0,18

Oil of Valerian 0,04

The Melissa oil 0,04

Oil x the El 0,04

Homeopathic essence of mistletoe 0,18

Homeopathic essence of jaborandi 0,18

Dense extract of lady's bedstraw 0,18

Dense extract component 0,18

The basis of the rest

The third option is a suppositories, containing in addition to homeopathic oil extract, cocoa butter, beeswax, propolis, lanolin, advanced oil series, homeopathic essence Likopodija, homeopathic essence of Kantaris, dense extract of lady's bedstraw, dense extract component with the following ratios of components in g on 1 suppository mass 2,

Homeopathic oil extract 0,18

Oil series 0,18

Homeopathic essence Likopodija 0,18

Homeopathic essence of Kantaris 0,18

Dense extract of lady's bedstraw 0,18

Dense extract component 0,18

The basis of the rest

All the proposed formulations of medicinal plants known and used in homeopathy. Homeopathic essences prepared from equal parts of juice and 90% ethyl alcohol (Homeopathic medicines, guide and manufacturing, Wilmar Schwabe, edited by Whirimako, Moscow, 1967, p.15-16).

Thick extracts component and lady's bedstraw is prepared from a liquid. The ratio of raw materials-extractant (1:8) by the method of evaporation to a residual moisture content of 25%.

Technology is a homeopathic oil extract is as follows: an equal number of fruits 0.5 g of sea buckthorn, grass clover, grass, sage, flowers of acacia pour 95° alcohol in a ratio of 1:2 (4 ml) to mirrors for 24 hours, then add olive oil (4 g), steamed in a water bath for 6-8 hours. Filtered. The basis for candles made from cocoa butter, beeswax, propolis, lanolin, as follows:

100 g basis separately melt 15 g of propolis in a water bath to dissolve in hot, filter. Separately melt 15 g beeswax with 30 g of cocoa butter to dissolve and immediately filtered. In this hot weight enter hot propolis. And get the mixture (oil, beeswax). Then 30 g of boiling cocoa butter injected the mixture (oil, beeswax), a little cool and add 10 g of lanolin, mix until completely cooled.

Specific example suppository composition No. 1

100 suppository beat of sea buckthorn oil 18 g, homeopathic oil extract 18 g, oil of thuja 9 g of tea tree oil 9 g, oil of juniper 9 g, homeopathic essence of eucalyptus 9 g, homeopathic essence elderflower 9 g, homeopathic essence of wormwood 9, dense extract of lady's bedstraw 10 grams of thick extract component 10 g, 90 basis,

Pre-made, as described above, the base of the suppository and homeopathic oil extract, then homeopathic essences grind is with 50 g basis, then in the remaining 40 g melted basics add oil and homeopathic oil extract at a temperature of oils 37°C, the mixture is thoroughly mixed among themselves until a homogeneous mass. Suppositories are prepared by the method of splashing in a special metal or plastic forms.

A specific example of the composition No. 2

100 candles give of sea buckthorn oil 18 g, homeopathic oil extract 18 g, Valerian oil 4 g, oil of lemon balm 4 g, oil of hops 4 g, homeopathic essences mistletoe 18 g, homeopathic essences, jaborandi 18 g thick extract of lady's bedstraw 18 g thick extract component 18 g, fundamentals of 80,

Pre-made, as described above, the base of the suppository and homeopathic oil extract, then homeopathic essences triturated with 40 g basis, then the remaining 40 g melted basics add oil and homeopathic oil extract at a temperature of oils 37°C, the mixture is thoroughly mixed among themselves until a homogeneous mass. Suppositories are prepared by the method of splashing in a special metal or plastic forms.

A specific example of the composition No. 3

100 suppository weighed homeopathic oil extract 18 g oil series 18 g, homeopathic essences Likopodija 18 g, homeopathic essences is Antares 18 g, thick extract of lady's bedstraw 18 g thick extract component 18 g, bases 92,

Pre-made, as described above, the base of the suppository and homeopathic oil extract, then homeopathic essences triturated with 40 g basis, then in the remaining 42 g of molten basics add oil and homeopathic oil extract at a temperature of oils 37°C, the mixture is thoroughly mixed among themselves until a homogeneous mass. Suppositories are prepared by the method of splashing in a special metal or plastic forms.

The proposed formulations homeopathic suppositories have the following physicochemical characteristics: (GF XI issue 2, s article "suppositories")

The full deformation of not more than 7 minutes

Melting point not higher 33,5°C.

The acid number of not more than 4.0 mg KOH.

Therapeutic activity of the proposed formulations of suppositories were studied on the basis of the homeopathic center "Verbena" , Pyatigorsk.

Example 1

Sick Colias 1963. He complained of lower back pain. Frequent urination, cheesy white discharge.

Diagnosis: fungal colpitis, vaginal dryness.

Purpose: candle composition No. 1 by one candle in the morning and at night for 1 month.

The dynamics of the disease: after 5 days disappeared back pain, mochai is blowing recovered. After 10 days of application disappeared Beli, improved health.

Re turnout in 20 days. After inspecting the mucosa was normal.

Example # 2

Smetanina E.V., born in 1970.

The diagnosis of fibroids 10 weeks, painful menstrual cycle is delayed by 5-7 days, dragging pain in the abdomen, cervical erosion.

Purpose: Candle composition No. 2 in the morning and evening for 1 month.

The dynamics of the disease: feel better after 5 days of candles, dragging pain in the abdomen disappeared, erosion decreased. After 10 days of application, the delay was reduced to 1 day. Re turnout in 20 days. After the ultrasound showed reduction of fibroids up to 6 weeks. Repeat the treatment after 10 days, according to the same scheme.

Example # 3

Patient Egorova LT, born in 1960.

Diagnosis: endometriosis pain during the menstrual cycle, vaginal dryness.

Purpose: candle composition No. 2 in the morning and in the evening, one candle deep into the vagina for 1 month.

The dynamics of the disease: feel better after 5 days of candles, the pain disappeared. After re-admission noted positive dynamics of treatment, mucous came back to normal after 10 days of candles. After the ultrasound the observed decrease in proliferation of the endometrium. Slimy pink moist. The burning sensation and discomfort is missing.

Example No. 4

Patient Klimenko, 1967.

Diagnosis: yellowish-brown allocation, fungal colpitis, cervical erosion.

Purpose: candle composition No. 3 in the morning and in the evening, one candle deep into the vagina for 1 month.

The dynamics of the disease: feel better after 5 days of candles, the selection is gone. After re-admission noted positive dynamics of treatment. After 7 days of receiving noticed scarring erosion. Further treatment to consolidate the achievements made within 1 day.

Example No. 5

Patient Ovcharenko HE, born in 1978.

Diagnosis: Fungal colpitis, endometriosis, erosion, yellowish discharges.

Purpose. Candle composition No. 3 in the morning and in the evening, one candle within 30 days.

The dynamics of the disease: after five days of treatment disappeared selection. After 15 days of treatment was the reduction of proliferation of the endometrium and reducing the diameter of erosion. After treatment ultrasound indicated a suspension of proliferation of the endometrium, feeling good.

Thus, we can conclude that the proposed compositions have high pharmacological activity and can be used to treat not only such as diseases like obesity, vulvovaginitis, endometriosis, papilloma, fibroids, and zrozii cervical and vaginal dryness.

1. The homeopath is ical suppositories for the treatment of fungal obesity, vulvovaginitis, endometriosis, warts, cervical erosion, candidiasis and vaginal dryness, containing homeopathic oil extract, sea buckthorn oil, homeopathic essences of eucalyptus, elderflower, sage, oil of thuja, tea tree oil, juniper oil, characterized in that it further contain dense extract of lady's bedstraw and dense extract component with the following ratios in g on 1 suppository mass 2,
Sea buckthorn 0,18
Homeopathic oil extract 0,18
Oil of thuja 0,09
Tea tree oil 0,09
Juniper 0,09
Homeopathic essence of eucalyptus 0,09
Homeopathic essence elderflower 0,09
Homeopathic essence of wormwood 0,09
Dense extract of lady's bedstraw 0,1
Dense extract component 0,1
The basis of the rest

2. Homeopathic suppositories for the treatment of fungal obesity, vulvovaginitis, endometriosis, warts, cervical erosion, candidiasis and vaginal dryness, containing homeopathic oil extract, sea buckthorn oil, homeopathic essence of mistletoe, characterized in that it further contains Valerian oil, Melissa oil, hop oil, homeopathic essence of jaborandi, dense extract of lady's bedstraw and dense extract component with the following ratios of components in g on 1 suppository mass 2,
Oil is blaike 0,18
Homeopathic oil extract 0,18
Oil of Valerian 0.04
The Melissa oil 0,04
Oil of hops 0.04
Homeopathic essence of mistletoe 0,18
Homeopathic essence of jaborandi 0,18
Dense extract of lady's bedstraw 0,18
Dense extract component 0,18
The basis of the rest

3. Homeopathic suppositories for the treatment of fungal obesity, vulvovaginitis, endometriosis, warts, cervical erosion and vaginal dryness, containing homeopathic oil extract, characterized in that it further contain oil series, homeopathic essence Likopodija, homeopathic essence of Kantaris, dense extract of lady's bedstraw, dense extract component with the following ratios of components in g on 1 suppository mass 2,
Homeopathic oil extract 0,18
Oil series 0,18
Homeopathic essence Likopodija 0,18
Homeopathic essence of Kantaris 0,18
Dense extract of lady's bedstraw 0,18
Dense extract component 0,18
The basis of the rest



 

Same patents:

FIELD: chemistry.

SUBSTANCE: invention relates to use of 2-nitroheterylthiocyanates, particularly 4-rhodano-5-nitropyrimidine and 2-rhodano-3-nitripyridine derivatives of general formula (I), optionally in crystalline form or in form of pharmaceutically acceptable addition salts thereof with acids or bases, having activity on fungal strains, fungal infection agents, for producing pharmaceutical compositions that are suitable for local application. The compounds are also active on strains that are resistant to existing drugs. In general formula (I) X=N or C-R3, R1 denotes a proton, a saturated or unsaturated linear alkoxy radical having 1-5 carbon atoms; a cycloalkyloxy radical having up to 6 carbon atoms; a saturated linear alkylmercapto radical having 1-3 carbon atoms; an amino radical having 1-10 carbon atoms, selected from a saturated or unsaturated linear mono- or dialkylamino radical or a cycloalkylamino radical, cyclic amino radical. Each of the cyclic groups can be substituted with 1-2 methyl groups, or a benzylamino group; R2 denotes a proton, a saturated or unsaturated linear alkyl radical having 1-5 carbon atoms, or a cyclic aliphatic radical having up to 6 carbon atoms, trifluoromethyl, styryl or methylmercapto group; R3 denotes a trifluoromethyl, formyl, acetyl, nitro, benzoyl, cyano group or an alkoxycarbonyl substitute having 1-3 carbon atoms in the alkoxy group.

EFFECT: improved properties of compounds.

5 cl, 3 tbl, 21 ex

FIELD: chemistry.

SUBSTANCE: invention relates to a water-soluble amide derivative of salicylic acid, specifically a sodium salt of ethyl ether of N-salicyloylglycine (2-[(2-ethoxy-2-oxoethl)carbomoyl]sodium phenolate) , and can be used in chemical and pharmaceutical industry.

EFFECT: sodium salt of ethyl ether of N-salicyloylglycine, having antibacterial, antifungal and antilysozymic activity.

3 tbl, 4 ex

FIELD: biotechnologies.

SUBSTANCE: invention refers to conjugate of gossypol with sodium-carboxymethyl cellulose with molecular mass of 780-180000 Da at the ratio of gossypol to sodium-carboxymethyl cellulose of (1-5):(99-95) wt % and content of low-molecular fraction with molecular mass of 780 to 1500 Da of up to 20% and high-molecular fraction with molecular mass of 1500 to 180000 Da of up to 80%, conjugate of gossypol with sodium-carboxymethyl cellulose with molecular mass of 780 to 1500 Da at the ratio of gossypol to sodium-carboxymethyl cellulose of (0.35-1.76):(99.65-98.24) wt %, and conjugate of gossypol with sodium-carboxymethyl cellulose with molecular mass of 1500 to 180000 Da at the ratio of gossypol to sodium-carboxymethyl cellulose of (0.65-3.23):(99.35-96.77) wt %, and their production methods. Besides, the invention refers to antiviral agents on the basis of the above conjugates and pharmaceutical compositions containing conjugates.

EFFECT: improving compound application efficiency.

21 cl, 5 tbl, 3 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, pharmaceutics and nanotechnology, more specifically to a pharmaceutical composition of fluconazole that is an antifungal agent from the group of triazole prepared by chemical synthesis, and a method for preparing it. The presented pharmaceutical composition possessing antifungal activity containing fluconazole coating nanotubes of the various external tube diameter - 60-160 nm, the internal diameter - 10-60 nm and the length - 100-5000 nm in the following relations, wt %: fluconazole - 50-60; alumosilicate nanotubes - 40-50. The method for preparing the pharmaceutical composion consists in the fact that fluconazole is mixed with the alumosilicate nanotubes with the aqueous ethanol environment, and mixing the prepared suspension and evaporating ethanol.

EFFECT: using fluconazole applied on the nanotubes enables developing new ointments and gels for treating fungal diseases with the reduced amount of fluconazole.

2 cl, 2 dwg, 1 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention refers to using Furacilin as a photosensitiser.

EFFECT: invention enhances the antimicrobial activity of Furacilin when exposed to light the spectral range of which corresponds to the electronic absorption spectrum of Furacilin.

1 tbl, 2 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to hygiene and may be used for skin preparation for protection against infection, for foot skin and footwear disinfection for mycosis prevention. The formulation contains poly-(4,9-dioxaadodecane guanidine) chloride, phosphate or succinate, methylisothiazolinone, sorbitol, zinc acetate, dish mustard extract and water.

EFFECT: invention provides higher biocidal activity of the formulation, reduced toxicity and improved application properties.

2 tbl, 6 ex

FIELD: medicine.

SUBSTANCE: invention refers to veterinary science. Using ORF-2 PCV-2 protein for preparing an immunogenic composition applicable for relieving concurrent infections caused by one or more viral (e.g. PRRS), bacterial and/or fungal pathogens (e.g. Actinobacillus pleuropneumoniae, Haemophilus parasuis, Mycoplasma hyrhinis, Mycoplasma hyopneumoniae, Pasteurella multocida, Salmonella spp., or Strepococcus suis) different from PCV2 in pigs or pig herds with a percent of the concurrent infections in relation to one or more infections are reduced by more than 10% as compared to an unvaccinated reference group.

EFFECT: relieving the concurrent infections caused by one or more viral (eg PRRS), bacterial and/or fungal pathogens.

8 cl, 2 tbl, 1 ex, 11 dwg

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine and deals with application of special peptides in cosmetic compositions for treatment or prevention of dandruff; and cosmetic compositions for treatment or prevention of dandruff, which contain claimed peptides.

EFFECT: group of inventions ensures efficiency against lipophilic fungus species, in particular Malassezia furfur, which causes dandruffl and inhibiting activity against Malassezia furfur, which is much higher, than inhibiting activity, achieved by means of peptide AFPP.

12 cl, 66 ex, 19 tbl

FIELD: biotechnologies.

SUBSTANCE: compound is proposed with a formula

specified below, or its pharmaceutically acceptable salt, representing a nystatin derivative, having an additional double link, available between C28 and C29, and additionally modified relative to nystatin according to position C16. These compounds are used as antifungal agents. Also in the invention a pharmaceutical composition is announced, and its manufacturing to treat fungal infections, as well as the method to treat a fungal infection of an animal, including introduction of an efficient compound dose to the specified animal.

EFFECT: improved efficiency of compound application.

10 cl, 29 ex, 17 dwg, 15 tbl

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to microencapsulation of drugs through the example of rivanol which can be used as an antimicrobial, antifungal topical preparation. A method for preparing microcaplues of rivanol in a water-soluble polymer representing polyvinyl alcohol or polyvinyl pyrrolidone is implemented by physical-chemical precipitation with a solvent wherein a precipitant is acetone. The process is carried out at 25°C with no special equipment required.

EFFECT: method for preparing the microcapsules of rivanol provides simplifying the process of microencapsulation.

13 dwg, 5 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely to a method for preparing a therapeutic hydrogel material involving mixing an aqueous solution of sodium alginate and a drug preparation, dispersing a cross-linking agent that is presented by calcium sulphate in glycerol in the concentration of 0.8-2.5%, mixing the dispersion with the prepared mixture of sodium alginate with the drug preparation in ratio 1-2:4-6, placing the prepared product into a tiling pattern and keeping it till form-stable, conducting gamma sterilisation; the formation process involves the mechanical stability measurements with the diametral compression of the formed hydrogel; the hydrogel is considered to be formed once a thickness of the formed hydrogel varies with the diametral compression by 10-30%.

EFFECT: invention provides the wider medical variation of the drug concentrations, preparing high-thixotropy soft hydrogel materials (tablets) easy to administer, including through rectum, preparing the materials that preserve its all their physical-technical and mechanical properties after the gamma sterilisation along with the sterility.

4 cl, 10 ex

FIELD: biotechnologies.

SUBSTANCE: group of inventions refers to microbiology and biotechnology. Proposed strains Lactobacillus crispatus "ВКМ" B-2727D, Lactobacillus gasseri "ВКМ" B-2728D and Lactobacillus plantarum "ВКМ" B-2731D have antagonistic activity in relation to pathogenic and semi-pathogenic microorganisms. Besides, the invention proposes a consortium based on the above strains for production of a bacterial preparation, a biologically active additive, and direct inoculation for obtaining fermented milk product of functional nutrition.

EFFECT: consortium has higher antagonistic activity against pathogenic and semi-pathogenic microorganisms in relation to individual strains of lactobacilli, use of a consortium will allow enlarging the range of devices intended for prophylaxis and treatment of urogenital infections of females.

4 cl, 1 dwg, 7 tbl, 12 ex

FIELD: medicine.

SUBSTANCE: what is presented is using oestriol for preparing a pharmaceutical dosage form for the vaginal administration of oestriol in a dose of 0.1 mg/day or less for preventing and/or treating urogenital atrophy in females prone to a high probability of the development of oestrogen-dependent tumour or the patients suffering or suffered from oestrogen-dependent tumour.

EFFECT: it is shown that oestriol has the limited absorption from the declared dosage form that reduces its systemic exposure as compared to the control preparation that is "Ovestinon®" cream containing oestriol 0,1% with the effective elimination of vaginal atrophy.

24 cl, 1 dwg, 7 tbl

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a composition for local application for treating vaginitis of various origins and related inflammatory inflammations. The above composition contains benzophenanthridine alkaloids, benzofuran compounds and optionally Zanthoxylum bimgeanum or Echinacea angustifolia extract.

EFFECT: composition possesses antibacterial, antifungal and antienzymic activity and reduces vaginal infections fast, eliminates the presence of saprophytes, relieves inflammation, itch and vaginal pH.

12 cl, 3 tbl, 1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a composition for oral hygiene and for treating and preventing pathological conditions related to the dentofacial system, implants and complications following the oral surgeries. The above composition contains benzophenanthridine alkaloids, benzofuran compounds and catechine polyphenols.

EFFECT: composition possesses antibacterial, antifungal and antienzymic activity that exceeds total activities of the different ingredients if used separately.

14 cl, 2 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely gynaecology and may be used for individual selection of the preparations containing the probiotic lactic bacterial strains for effective intravaginal therapy. For this purpose, vaginal epithelial cells are recovered from the patient, released from the accompanying microflora. That is followed by preparing an epithelial cell suspension in a culture medium, and mixed with a suspension of thermally-activated probiotic lactic bacterial strains. Then, the suspension is incubated; the epithelial cell culture fluid filtrate is prepared and added to the suspension of the tested probiotic lactic bacterial strains in ratio 1:7. Concurrently, a reference of the mixture of the epithelial cell culture medium and the suspension of the tested probiotic lactic bacterial strains in ratio 1:7 is prepared. The test and reference samples are incubated, measured for optical density; and a degree of biomass increase in the test sample is related to that in the reference. The preparation containing the probiotic lactic bacterial strains the biomass increase of which under the influence of patient's vaginal epithelial cells is stimulated most is selected form the effective intravaginal therapy.

EFFECT: invention enables the individual selection of the preparations containing the probiotic lactic bacterial strains for the effective intravaginal therapy.

3 ex, 1 tbl, 2 dwg

FIELD: medicine.

SUBSTANCE: invention relates to field of medicine and is intended for treatment of vaginal infections. Method includes complex therapy with application of immunocorrector. As immunocorrector solution of medicine Betaleukin, introduced intravaginally during 40-90 minutes daily at least during 5 days, is applied.

EFFECT: method is highly efficient in complex therapy of vaginal infections.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to an agent for vaginal douche in the first phase of treatment of bacterial vaginosis. The agent for vaginal douche in the first phase of treatment for bacterial vaginosis, which represents a powder containing kitchen salt, citric acid, dry extract of chamomile (Matricaria chamomilla L) and sorbitol in the specific ingredient percentage.

EFFECT: agent allows reducing the length of the treatment of bacterial vaginosis and promotes normalising the natural vaginal flora.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to an agent for vaginal douche in the first phase of treatment of thrush (vaginal yeast). The agent for vaginal douche in the first phase of treatment for thrush (vaginal yeast), which represents a powder containing kitchen salt, baking powder and dry extract of chamomile (Matricaria chamomilla L) in the specific ingredient percentage.

EFFECT: agent is effective for vaginal douche in the first phase of treatment of thrush (vaginal yeast), eliminates the risk of a local allergic reaction.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to an agent for vaginal douche. The agent for vaginal douche in the phase of vaginal microflora recovery following the treatment of bacterial vaginosis, vaginal thrush (vaginal yeast) containing acetic acid sodium salt, lactose, dry extract of marigold (Calendula officinalis) in the following proportions.

EFFECT: agent promotes the effective recovery of a normal vaginal flora, provides hygienic cleaning of the vagina from its discharge and vaginal microorganisms during the procedure, eliminates the risk of local allergic reactions.

FIELD: medicine.

SUBSTANCE: invention represents a pharmaceutical composition for treating local manifestations of herpes simplex infections and for preventing influenza and acute respiratory viral infections, containing green tea extract and epigallocatechin-3-gallate (EGCG) 70-90 wt %, colloidal silver and a gel-forming base with the ingredients of the composition taken in certain ratio, wt %.

EFFECT: high clinical effectiveness.

6 cl, 8 ex, 5 tbl

Up!